Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Oral tolerance therapy for transplant rejection from AutoImmune to enter clinic

Nov. 15, 1996

Aquila's pneumococcal immunotherapeutic enters clinical trials

Nov. 15, 1996

Lilly to manufacture SangStat generic immunosuppressant

Nov. 15, 1996

ImmuLogic's Allervax products available for licensing

Nov. 8, 1996

FDA advisory committee deems ACEL-IMUNE safe and effective for use in infants

Nov. 8, 1996

ImClone licenses NIH patent for stem cell and gene therapy

Nov. 8, 1996

Bacterial meningitis virtually eliminated in U.S. following introduction of Hib vaccine

Nov. 8, 1996

Novel DNA vaccine induces immune response to HSV-2

Nov. 1, 1996

StressGen's core technology receives patent protection

Nov. 1, 1996

Three-dimensional structure of the T-cell receptor determined

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...